A similar kind of observation comes out like normalization of tumor blood vessels, and a decreased tumor blood volume results in the prolongation of the survival in an animal model of brain metastasis and glioma patients treated with cediranib or bevacizumab, an anti-VEGF antibody (Lorger, 2012). Here, VEGFA is linked to neoplasm.